Job/Unit: O20637
/KAP1
Date: 30-07-12 11:46:06
Pages: 9
T. Pathak et al.
2 H) ppm; 13C NMR (CDCl3): δ = 21.5, 46.0, 54.8, 66.3, 70.4
FULL PAPER
Compound 11RS: Yield 0.57 g (55%); [α]2D6 = –100.84 (c = 0.10,
1
CHCl3); H NMR (CDCl3): δ = 2.39 (s, 3 H), 2.93 (s, 1 H), 3.42 (CH2), 73.6 (CH2), 74.5 (CH2), 78.4, 105.6, 124.9, 127.8 (2ϫ C),
(s, 3 H), 3.45–3.47 (m, 1 H), 3.61–3.65 (m, 1 H), 3.79 (t, J = 8.4 Hz,
128.4, 130.2, 137.5, 139.2, 142.8 ppm; HRMS (ESI+): calcd for
1 H), 4.28 (q, J = 5.6, 12.4 Hz, 1 H), 4.54 (d, J = 11.2 Hz, 1 H), C21H25O6NSNa [M + Na]+ 442.1300; found 442.1307.
4.62 (d, J = 11.2 Hz, 1 H), 4.84 (d, J = 8.0 Hz, 1 H), 4.88 (s, 1 H),
Compound 18SS: Compound 9SS (0.40 g, 1.11 mmol) was con-
7.24–7.37 (m, 7 H), 7.53 (d, J = 8 Hz, 2 H) ppm; 13C NMR
verted into 18SS (0.26 g, 55%) by following the general procedure
(CDCl3): δ = 21.4, 56.0, 70.3 (CH2), 71.7, 73.6 (CH2), 76.7, 77.4,
described above. [α]2D6 = +210.51 (c = 0.08, CHCl3); 1H NMR
109.9, 124.8, 127.9, 128.1, 128.4, 130.0, 137.4, 140.2, 142.0 ppm;
(CDCl3): δ = 2.39 (s, 3 H), 2.76 (dd, J = 3.2, 10.8 Hz, 1 H), 3.03–
HRMS (ESI+): calcd for C20H24O5SNa [M + Na]+ 399.1242;
3.06 (m, 1 H), 3.39 (s, 3 H), 3.41–3.45 (m, 1 H), 3.49–3.54 (m, 1
found 399.1234.
H), 4.06–4.07 (m, 1 H), 4.13 (dd, J = 4.8, 13.6 Hz, 1 H), 4.26–4.33
Compound 13SS: Compound 10 (1.0 g, 2.78 mmol) was converted
into 13SS (0.42 g, 40%) by following the general procedure de-
scribed above. [α]2D6 = +58.86 (c = 0.15, CHCl3); 1H NMR (CDCl3):
δ = 1.39 (s, 1 H), 2.42 (s, 3 H), 3.35–3.38 (m, 1 H), 3.41 (s, 3 H),
3.86 (s, 1 H), 3.97–4.02 (m, 1 H), 4.12 (dd, J = 2.8, 10.4 Hz, 1 H),
4.68 (d, J = 1.6 Hz, 2 H), 4.79–4.80 (m, 2 H), 7.26–7.43 (m, 7 H),
7.61 (d, J = 8 Hz, 2 H) ppm; 13C NMR (CDCl3): δ = 21.5, 55.3,
70.2 (CH2), 73.4 (CH2), 74.0, 76.5, 79.4, 108.9, 125.6, 127.6, 127.8,
128.3, 130.0, 130.2, 138.0, 138.9, 142.6 ppm; HRMS (ESI+): calcd
for C20H24O5SNa [M + Na]+ 399.1242; found 399.1241.
(m, 2 H), 4.52 (d, J = 12.0 Hz, 1 H), 5.01 (s, 1 H), 7.21–7.26 (m, 4
H), 7.31–7.38 (m, 3 H), 7.48 (d, J = 8 Hz, 2 H) ppm; 13C NMR
(CDCl3): δ = 21.4, 44.5, 55.1, 66.7, 68.3 (CH2), 73.4 (CH2), 75.2
(CH2), 76.1, 106.3, 124.6, 127.8, 127.9, 128.5, 130.2, 137.2, 139.1,
142.7 ppm; HRMS (ESI+): calcd for C21H25NO6SNa [M + Na]+
442.1300; found 442.1302.
Compound 20RS: Compound 15RS (0.50 g, 1.39 mmol) was con-
verted into 20RS (0.30 g, 53%) by following the general procedure
described above. [α]2D6 = –132.81 (c = 0.15, CHCl3); 1H NMR
(CDCl3): δ = 2.38 (s, 3 H), 2.75–2.79 (m, 1 H), 3.04 (dd, J = 2.8,
10.4 Hz, 1 H), 3.38 (s, 4 H), 3.44–3.47 (m, 1 H), 4.19 (d, J = 12 Hz,
1 H), 4.36 (d, J = 12 Hz, 1 H), 4.51–4.52 (m, 1 H), 4.68–4.74 (m,
1 H), 4.88 (d, J = 4.0 Hz, 1 H), 5.10–5.16 (m, 1 H), 7.05–7.35 (m,
9 H) ppm; 13C NMR (CDCl3): δ = 21.3, 46.1, 56.1, 63.3, 71.8
(CH2), 72.4 (CH2), 72.9 (CH2), 73.0, 105.0, 123.8, 127.5, 127.6,
128.3, 130.0, 136.7, 137.7, 141.7 ppm; HRMS (ESI+): calcd for
C21H25NO6SNa [M + Na]+ 442.1300; found 442.1309.
Compound 15RS: Compound 11RS (1.19 g, 3.16 mmol) was con-
verted into 12RS by following the general procedure described
above. Compound 12RS (1.30 g, 2.86 mmol) was directly converted
into 15RS (0.865 g, 84%) by following the general procedure de-
scribed above. [α]2D6 = –188.43 (c = 0.11, CHCl3); 1H NMR
(CDCl3): δ = 2.38 (s, 3 H), 3.41 (s, 3 H), 3.52–3.56 (m, 1 H), 3.61–
3.64 (m, 1 H), 4.39 (t, J = 6.0 Hz, 1 H), 4.53 (dd, J = 11.6, 19.6 Hz,
2 H), 5.73 (s, 1 H), 6.53 (s, 1 H), 7.22–7.39 (m, 7 H), 7.43 (d, J =
8 Hz, 2 H) ppm. 13C NMR (CDCl3): δ = 21.4, 54.9, 72.6 (CH2),
73.6 (CH2), 82.3, 108.4, 125.6, 127.9, 128.0, 128.4, 128.8, 130.1,
137.4, 138.8, 142.4, 154.2 ppm. HRMS (ESI+): calcd for
C20H22O4SNa [M + Na]+ 381.1137; found 381.1138.
Compound 21SS: Compound 16SS (0.45 g, 1.25 mmol) was con-
verted into 21SS (0.24 g, 46%) by following the general procedure
described above. [α]2D6 = +1.23 (c = 0.13, CHCl3); 1H NMR
(CDCl3): δ = 2.44 (s, 3 H), 2.50–2.53 (m, 1 H), 3.17–3.20 (m, 1 H),
3.40 (s, 3 H), 3.60 (dd, J = 5.6, 13.2 Hz, 1 H), 3.91–4.00 (m, 1 H),
4.04–4.08 (m, 1 H), 4.26 (dd, J = 2.8, 10.4 Hz, 1 H), 4.69–4.73 (m,
3 H), 4.84 (d, J = 2.0 Hz, 1 H), 7.26–7.42 (m, 7 H), 7.62 (d, J =
8 Hz, 2 H) ppm; 13C NMR (CDCl3): δ = 21.5, 46.3, 55.5, 69.3, 70.0
(CH2), 73.6 (CH2), 74.1 (CH2), 79.6, 106.0, 125.6, 127.7, 127.9,
128.4, 130.4, 137.9, 138.8, 143.3 ppm; HRMS (ESI+): calcd for
C21H25NO6SNa [M + Na]+ 442.1300; found 442.1317.
Compound 16SS: Compound 13SS (0.56 g, 1.49 mmol) was con-
verted into 14SS by following the general procedure described
above. Compound 14SS (0.50 g, 1.10 mmol) was directly converted
into 16SS (0.331 g, 84%) by following the general procedure de-
scribed above. [α]2D6 = +93.69 (c = 0.03, CHCl3); 1H NMR (CDCl3):
δ = 2.41 (s, 3 H), 3.41 (s, 3 H), 3.49–3.53 (m, 1 H), 3.69 (dd, J =
3.2, 10.4 Hz, 1 H), 4.48 (dd, J = 12.0, 18.4 Hz, 2 H), 4.88–4.90 (m,
1 H), 5.69 (s, 1 H), 6.25 (s, 1 H), 7.26–7.35 (m, 7 H), 7.50 (s, J =
8 Hz, 2 H) ppm; 13C NMR (CDCl3): δ = 21.4, 55.1, 72.5 (CH2),
73.2 (CH2), 83.3, 107.7, 125.1, 127.5, 127.6, 128.2, 130.1, 132.0,
137.9, 138.5, 142.4, 150.5 ppm; HRMS (ESI+): calcd for
C20H22O4SNa [M + Na]+ 381.1137; found 381.1120.
Compound 24SS: Compound 23 (2.0 g, 5.15 mmol) was converted
into 24SS (1.73 g, 83%) by following the general procedure de-
scribed above. [α]2D6 = +192.56 (c = 0.10, CHCl3); 1H NMR
(CDCl3): δ = 3.54 (s, 3 H), 3.74–3.80 (m, 1 H), 3.89 (s, 1 H), 4.33–
4.38 (m, 3 H), 4.49 (d, J = 5.6 Hz, 1 H), 4.74–4.75 (m, 1 H), 4.80
(s, 1 H), 5.32 (s, 1 H), 7.00 (d, J = 7.2 Hz, 2 H), 7.19–7.37 (m, 6
H), 7.69 (d, J = 7.6 Hz, 2 H) ppm; 13C NMR (CDCl3): δ = 55.1,
61.0, 66.0, 66.4, 69.2 (CH2), 75.0, 101.0, 101.7, 125.9, 126.9, 127.8,
131.3, 136.5, 145.2 ppm; HRMS (ESI+): calcd for C20H23O6S [M
+ H]+ 391.1365; found 391.1323.
General Procedure for Nitromethane Addition: To a well-stirred
solution of NaH (8 equiv.) in DMF (5 mL/mmol) or 1,4-dioxane
(5 mL/mmol) was added nitromethane (11 equiv.) and the mixture
was stirred for 0.5 h at ambient temperature under an inert atmo-
sphere. The appropriate vinyl sulfone-modified carbohydrate
(1 equiv.) was added and the mixture was stirred for 2–3 h at 50–
60 °C. The reaction mixture was then partitioned between aqueous
saturated NaHCO3 and EtOAc (3ϫ 10 mL). The combined organic
layer was dried with anhydrous Na2SO4, filtered, and the filtrate
was concentrated under reduced pressure to give a residue that was
purified over silica gel to afford the title compound.
Compound 25SS: Compound 24SS (0.64 g, 1.64 mmol) was mesyl-
ated by following the general procedure. The crude mesylate was
converted into vinyl sulfoxide 25SS (0.50 g, 82%) by following the
general procedure described above. [α]2D6 = +77.08 (c = 0.06,
1
CHCl3); H NMR (CDCl3): δ = 3.49 (s, 3 H), 3.67–3.74 (m, 2 H),
4.00–4.06 (m, 1 H), 4.29–4.32 (m, 1 H), 5.07 (s, 1 H), 5.29 (s, 1 H),
6.52–6.53 (m, 1 H), 7.41–7.52 (m, 8 H), 7.52–7.67 (m, 2 H) ppm;
13C NMR (CDCl3): δ = 56.3, 63.8, 69.1 (CH2), 74.3, 96.8, 101.8,
124.7, 125.3, 126.6, 128.4, 129.3 (2ϫ C), 131.7, 136.7, 142.2,
147.2 ppm; HRMS (ESI+): calcd for C20H21O5S [M + H]+
373.1110; found 373.1073.
Compound 17RS: Compound 8RS (0.50 g, 1.39 mmol) was con-
verted into 17RS (0.41 g, 69%) by following the general procedure
described above. [α]2D6 = –32.99 (c = 0.09, CHCl3); 1H NMR
(CDCl3): δ = 2.43 (s, 3 H), 2.71–2.75 (m, 1 H), 3.04–3.06 (m, 1 H),
3.39 (s, 3 H), 3.42–3.45 (m, 1 H), 3.82–3.89 (m, 2 H), 4.29–4.35 (m,
1 H), 4.49 (d, J = 12 Hz, 1 H), 4.57 (d, J = 11.6 Hz, 1 H), 4.74–
4.75 (m, 1 H), 4.88 (s, 1 H), 7.26–7.38 (m, 7 H), 7.56 (d, J = 8 Hz,
Compound 27SS: Compound 26 (2.0 g, 5.15 mmol) was converted
into 27SS (1.67 g, 80%) by following the general procedure de-
6
www.eurjoc.org
© 0000 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 0000, 0–0